Zimbabwe Eyes Greater Foreign Investment in Medicines Sector

Attracting Foreign Investment in a Growing Market

Harare - As Zimbabwe seeks to boost its economy, the country is poised to attract more foreign investment in the medicines sector. The growing demand for healthcare products has created an opportunity for international companies to tap into this market.

However, navigating the complex regulatory landscape of Zimbabwe can be a challenge for foreign investors. To gain access to the market, companies must obtain approvals from the Medicines Control Authority of Zimbabwe (MCAZ), the national medicines and healthcare products regulator.

Navigating Regulatory Complexities

To assist foreign companies in navigating these complexities, Freyr Zimbabwe offers a range of services designed to support clients in obtaining necessary approvals from MCAZ. These services include:

• Strategic Regulatory Consulting: Expert guidance on regulatory strategy and compliance.
• Regulatory Affairs and Intelligence: Stay up-to-date with the latest legislation and guidelines.
• Registration Pathways and License Management: Assistance with licensing and registration procedures.
• Marketing Authorization Maintenance: Support for maintaining marketing authorization.
• Regulatory Publishing and Submissions: Expert support for regulatory submissions.
• Dossier Management: Effective management of regulatory dossiers.

Why Choose Freyr Zimbabwe?

Freyr’s team of experts has extensive knowledge of the Zimbabwean regulatory regime and global regulatory affairs expertise. The company’s ability to provide proactive and collaborative support ensures that clients can get their products to market quickly while maintaining compliance with regional regulations. With its local regulatory knowledgebase and global expertise, Freyr is an ideal partner for foreign companies looking to invest in Zimbabwe’s medicines sector.